News
What’s the future of microbiome therapies in C. diff, cancer?
Preventive treatments for C. diff recurrence are in phase 3 trials, and oncologists are investigating microbiome-based differences in...
News
What’s the future of microbiome therapies in C. diff, cancer?
Preventive treatments for C. diff recurrence are in phase 3 trials, and oncologists are investigating microbiome-based differences in...
News
Spironolactone not linked to increased cancer risk in systematic review and meta-analysis
The data are “reassuring,” the authors reported.
News
Ear tubes not recommended for recurrent AOM without effusion, ENTs maintain
Guideline update reaffirms importance of attention to at-risk children with otitis media with effusion.
News
Derms in survey say climate change is impacting their patients
“Physicians, including dermatologists, are starting to understand the impact of the climate crisis on both their patients and themselves.”
News
A dermatologist-led model for CVD prevention in psoriasis may be feasible
The researchers see their findings as an early but promising step in finding better models to improve cardiovascular outcomes for patients with...
News
Antibiotic choices for inpatients with SSTIs vary by race
Clindamycin was more often prescribed for Black patients than White patients.
News
Prurigo nodularis has two disease endotypes, a cluster analysis shows
Black patients with PN appear more likely to have a distinct systemic inflammatory signature.
News
Hair follicle miniaturization common in persistent chemo-induced alopecia, case series suggests
Defined as absent or incomplete hair regrowth 6 months or more after completion of chemotherapy, pCIA has been increasingly reported in the...
News
Dr. Judy C. Washington shows URM physicians how to lead
She imparts a shared experience of being a minority in the field and helps prepare them for the challenges of facing racism.
News
Western diet promoted skin, joint inflammation in preclinical study
This new study found that WD-fed mice had less microbial diversity than that of mice fed a conventional diet.
News
Study estimates carbon footprint reduction of virtual isotretinoin visits
Virtual management of isotretinoin saved a median of 37.8 miles per visit during the study period of March 25 to Dec. 1, 2020.